Stevens Raymond C has filed 50 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 322230 shares of Structure Therapeutics Inc. ($GPCR) on March 19, 2026.
Activity breakdown: 1 open-market purchase and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 322230 | $0.00 | 322,230.0000 | 177,596,000 | 9999.99% | 0.18% |
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 260217 | $0.00 | 2,956,179.0000 | 177,596,000 | 9.65% | 0.15% |
| Nov. 20, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | American Depositary Shares | 824 | $0.00 | 5,824.0000 | 175,469,000 | 16.48% | 0.00% |
| March 3, 2026 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 53454 | $20.99 | 2,695,962.0000 | 177,596,000 | 1.94% | 0.03% |
| Jan. 30, 2026 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 159 | $218.89 | 7,047.0260 | 717,900,000 | 2.30% | 0.00% |
| Oct. 31, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 161 | $215.38 | 6,888.4800 | 717,900,000 | 2.39% | 0.00% |
| July 25, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 168 | $205.48 | 6,727.5880 | 737,200,000 | 2.57% | 0.00% |
| March 1, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 12495 | $7.92 | 2,675,769.0000 | 157,922,000 | 0.46% | 0.01% |
| May 21, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | American Depositary Shares | 1000 | $0.00 | 5,000.0000 | 172,051,000 | 25.00% | 0.00% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 16050 | $6.84 | 2,749,416.0000 | 172,351,000 | 0.58% | 0.01% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 89697 | $0.00 | 2,765,466.0000 | 172,351,000 | 3.35% | 0.05% |
| May 15, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Director stock option (right to buy) | 1478 | $0.00 | 1,478.0000 | 737,200,000 | 9999.99% | 0.00% |
| May 15, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Common Stock | 577 | $0.00 | 12,361.2070 | 737,200,000 | 4.90% | 0.00% |
| April 25, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 175 | $197.14 | 6,559.2070 | 737,200,000 | 2.74% | 0.00% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 340332 | $0.00 | 2,688,264.0000 | 157,922,000 | 14.49% | 0.22% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 826890 | $0.00 | 826,890.0000 | 157,922,000 | 9999.99% | 0.52% |
| Jan. 31, 2025 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 148 | $222.74 | 6,383.9870 | 737,200,000 | 2.37% | 0.00% |
| Oct. 25, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 134 | $245.39 | 6,236.1290 | 740,100,000 | 2.20% | 0.00% |
| July 26, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 120 | $273.19 | 6,102.0670 | 743,100,000 | 2.01% | 0.00% |
| June 12, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | M | Share Option (right to buy) | 99999 | $0.00 | 1.0000 | 139,710,000 | 100.00% | 0.07% |
| June 12, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | M | Ordinary Shares | 99999 | $0.39 | 2,297,931.0000 | 139,710,000 | 4.55% | 0.07% |
| June 12, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | M | Ordinary Shares | 50001 | $0.48 | 2,347,932.0000 | 139,710,000 | 2.18% | 0.04% |
| June 12, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | M | Share Option (right to buy) | 50001 | $0.00 | 488,766.0000 | 139,710,000 | 9.28% | 0.04% |
| June 10, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | S | American Depositary Shares | 185000 | $52.80 | 4,000.0000 | 139,710,000 | 97.88% | 0.13% |
| June 10, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | C | American Depositary Shares | 185000 | $0.00 | 189,000.0000 | 139,710,000 | 4625.00% | 0.13% |
| June 10, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | C | Ordinary Shares | 555000 | $0.00 | 2,197,932.0000 | 139,710,000 | 20.16% | 0.40% |
| May 15, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Common Stock | 390 | $0.00 | 11,207.0820 | 743,100,000 | 3.61% | 0.00% |
| May 15, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Director stock option (right to buy) | 1081 | $0.00 | 1,081.0000 | 743,100,000 | 9999.99% | 0.00% |
| April 26, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 133 | $246.58 | 5,982.0820 | 743,100,000 | 2.28% | 0.00% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 335481 | $0.00 | 335,481.0000 | 110,198,000 | 9999.99% | 0.30% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 335481 | $0.00 | 335,481.0000 | 110,198,000 | 9999.99% | 0.30% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 134682 | $0.00 | 2,752,932.0000 | 110,198,000 | 5.14% | 0.12% |
| Jan. 26, 2024 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 140 | $233.00 | 5,848.9430 | 743,100,000 | 2.45% | 0.00% |
| Oct. 27, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 174 | $187.88 | 5,708.9410 | 737,100,000 | 3.15% | 0.00% |
| July 28, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 125 | $260.07 | 4,916.2890 | 737,100,000 | 2.61% | 0.00% |
| May 15, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Director stock option (right to buy) | 1194 | $0.00 | 1,194.0000 | 737,100,000 | 9999.99% | 0.00% |
| May 15, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Common Stock | 430 | $0.00 | 9,083.1550 | 737,100,000 | 4.97% | 0.00% |
| April 28, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 137 | $236.91 | 4,791.1550 | 737,100,000 | 2.95% | 0.00% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | Chief Executive Officer | P | American Depositary Shares | 4000 | $15.00 | 4,000.0000 | 9,584,000 | 9999.99% | 0.04% |
| Feb. 2, 2023 | Structure Therapeutics Inc. | $GPCR | Stevens Raymond C | Chief Executive Officer | A | Stock option (right to buy) | 1600000 | $0.00 | 1,600,000.0000 | 9,584,000 | 9999.99% | 16.69% |
| Jan. 27, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | A | Phantom shares | 122 | $265.98 | 4,653.9440 | 737,100,000 | 2.69% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Director stock option (right to buy) | 2230 | $0.00 | 0.0000 | 737,100,000 | 100.00% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Director stock option (right to buy) | 2640 | $0.00 | 0.0000 | 737,100,000 | 100.00% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Director stock option (right to buy) | 3540 | $0.00 | 0.0000 | 737,100,000 | 100.00% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | S | Common Stock | 2230 | $264.24 | 8,394.1940 | 737,100,000 | 20.99% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Common Stock | 2230 | $131.05 | 10,624.1940 | 737,100,000 | 26.57% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | S | Common Stock | 2640 | $264.22 | 8,394.1940 | 737,100,000 | 23.93% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Common Stock | 2640 | $100.24 | 11,034.1940 | 737,100,000 | 31.45% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | S | Common Stock | 3540 | $264.33 | 8,394.1940 | 737,100,000 | 29.66% | 0.00% |
| Jan. 25, 2023 | DANAHER CORP /DE/ | $DHR | Stevens Raymond C | Director | M | Common Stock | 3540 | $83.28 | 11,934.1940 | 737,100,000 | 42.17% | 0.00% |